---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-024390"
form_type: "8-K"
ticker: "NVNO"
cik: "0001661053"
company_name: "enVVeno Medical Corp"
filed_at: "2021-10-01T23:59:59+00:00"
generated_at: "2026-06-28T23:59:40.199475+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Hancock Jaffe Laboratories renamed enVVeno Medical; new tickers NVNO and NVNOW

## Summary
- Name change effective 12:01 a.m. Eastern on October 1, 2021.
- Certificate of Amendment filed with Delaware Secretary of State on September 29, 2021.
- Common stock now trades as NVNO; warrants as NVNOW on Nasdaq.
- Company had previously been known as Hancock Jaffe Laboratories, Inc.

## SEC filing metadata
- accession: 0001493152-21-024390
- form_type: 8-K
- ticker: NVNO
- cik: 0001661053
- company_name: enVVeno Medical Corp
- filed_at: 2021-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661053/000149315221024390/0001493152-21-024390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661053/000149315221024390/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-024390
- JSON: https://secwatch.observer/filing/0001493152-21-024390.json
- Plain text: https://secwatch.observer/filing/0001493152-21-024390.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.